市場調査レポート
商品コード
1296779

経腸・非経口医療栄養市場の2028年までの予測-適応症、栄養タイプ、剤形、製品タイプ、投与経路、年齢層、流通経路別の世界分析

Enteral and Parenteral Medical Nutrition Market Forecast to 2028 - Global Analysis by Indication, Nutrition Type, Form, Product Type, Route of Administration, Age Group, and Distribution Channel

出版日: | 発行: The Insight Partners | ページ情報: 英文 720 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
経腸・非経口医療栄養市場の2028年までの予測-適応症、栄養タイプ、剤形、製品タイプ、投与経路、年齢層、流通経路別の世界分析
出版日: 2023年06月15日
発行: The Insight Partners
ページ情報: 英文 720 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経腸・非経口医療栄養市場規模は、2022年の173億4,000万米ドルから2028年には254億7,000万米ドルに成長すると予測されており、2023年から2028年までのCAGRは6.8%を記録すると推定されています。

経腸・非経口医療栄養市場の成長は、胃腸疾患の有病率の上昇、栄養不良や早産のケースの増加に起因しています。

消費者の積極的な健康管理を支援する製品、特にエネルギーレベル、免疫力、疾病治療といった特定のニーズに焦点を当てた製品に対する需要が急増しています。病気の種類によって必要な栄養は異なります。経腸・非経口製品の機能性と特異的な製剤は、患者に提供される既存の治療を妨げず、要件に従ってより正確で強化された治療を提供するのに役立ちます。経腸・非経口栄養のマクロおよび微量栄養素の製剤とその用途は、がんや消化器疾患などさまざまな疾患によって異なります。さらに、製薬会社は個別化された(患者固有の)成分を含む経腸・非経口栄養剤を提供しています。例えば、Impact(Nestle社提供)は、主要な待機的手術を受ける患者を管理し、術後の合併症や入院期間を減らし、臨床転帰を改善するための、臨床的に証明された栄養ソリューションです。このような独自のニーズに対応した製剤を提供する企業の取り組みは、経腸・非経口医療栄養市場の成長を促進すると思われます。

さらに、さまざまな団体が特定の栄養製剤の使用に関する認識を広める努力をしています。例えば、米国非経口・経腸栄養学会(American Society for Parenteral and Enteral Nutrition、ASPENと呼ばれる)は米国を拠点とする医療専門組織で、栄養士、薬剤師、医師・助手、看護師、看護実務者、科学者、学生、その他栄養のあらゆる分野の医療専門家を雇用し、患者に臨床栄養を提供し、患者を教育しています。こうした要因が、今後の経腸・非経口医療栄養市場の成長を支えると思われます。

目次

第1章 はじめに

第2章 主要な要点

第3章 調査方法

第4章 経腸・非経口医療栄養市場 - 市場展望

  • 概要
  • PEST分析
  • 専門家の意見
  • エネルギー含有量分析

第5章 経腸・非経口医療栄養市場 - 主な市場ダイナミクス

  • 市場促進要因
    • 胃腸疾患の有病率の上昇
    • 栄養不良症例の増加

第6章 経腸・非経口医療栄養市場-世界分析

  • 経腸・非経口医療栄養剤の世界市場収入予測と分析
  • 企業分析
  • 経腸・非経口医療栄養市場の市場シェア分析

第7章 経腸・非経口医療栄養の世界市場:2028年までの収益および予測 - 適応症別

第8章 経腸・非経口医療栄養の世界市場 - 2028年までの収益および予測- 栄養タイプ別

第9章 経腸・非経口医療栄養の世界市場 - 2028年までの収益および予測 - 剤形別

第10章 経腸・非経口医療栄養の世界市場:2028年までの収益および予測 - 製品タイプ別

第11章 経腸・非経口医療栄養の世界市場 - 2028年までの収益および予測 - 投与経路別

第12章 経腸・非経口医療栄養の世界市場-2028年までの収益および予測 - 年齢層別

第13章 経腸・非経口医療栄養の世界市場-2028年までの収益および予測 - 流通経路別

第14章 経腸・非経口医療栄養市場 - 2028年までの収益および予測 - 地域別分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第15章 COVID-19パンデミックが経腸・非経口医療栄養市場に与える影響

第16章 経腸・非経口医療栄養市場 - 産業の展望

第17章 企業プロファイル

  • Abbott Laboratories
  • Nestle SA
  • Nutricia International BV
  • Medtrition Inc
  • Fresenius Kabi AG
  • B. Braun SE
  • Smartfish AS
  • Nutrisens SAS
  • AYMES International Ltd
  • Medifood International SA
  • Easy Line Ltd
  • Charing Cross Scientific AS
  • Baxter International Inc
  • Medica Nutrition Inc

第18章 付録

図表

List Of Tables

List Of Figures

  • Figure 1. Enteral and Parenteral Medical Nutrition Market Segmentation
  • Figure 2. Enteral and Parenteral Medical Nutrition Market, By Region
  • Figure 3. Global Enteral and Parenteral Medical Nutrition Market Overview
  • Figure 4. Elderly Segment Held Largest Share of Indication Segment in Enteral and Parenteral Medical Nutrition Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Enteral and Parenteral Medical Nutrition Market, by Geography (US$ Million)
  • Figure 7. Global Enteral and Parenteral Medical Nutrition Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Enteral and Parenteral Medical Nutrition Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East and Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Enteral and Parenteral Medical Nutrition Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Enteral and Parenteral Medical Nutrition Market- By Geography Forecast and Analysis - 2022 & 2028
  • Figure 18. Market Positioning of Key Players in Enteral and Parenteral Medical Nutrition Market
  • Figure 19. Market Share Analysis of Key Players in Enteral and Parenteral Medical Nutrition Market (2022)
  • Figure 20. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
  • Figure 21. Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
  • Figure 36. Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Sole Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
  • Figure 39. Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
  • Figure 43. General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Disease Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
  • Figure 46. Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
  • Figure 50. Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
  • Figure 55. Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. North America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 60. North America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 61. North America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 62. US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 63. Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Europe: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 65. Europe Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Europe: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 67. Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 68. UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 69. France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 70. Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 71. Spain: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 72. Netherlands: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 73. Switzerland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 74. Poland: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 75. Sweden: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 76. Belgium: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 77. Rest of Europe: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 78. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 79. Asia Pacific Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 80. Asia Pacific: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 81. China: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 82. Japan: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 83. India: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 84. Australia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 85. South Korea: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 86. Indonesia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 87. Thailand: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 88. Vietnam: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 89. Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 90. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 91. Middle East & Africa Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 92. Middle East & Africa: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 93. Saudi Arabia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 94. South Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 95. UAE: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 96. Iran: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 97. Israel: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 98. Egypt: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 99. Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 100. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 101. South & Central America Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 102. South & Central America: Enteral and Parenteral Medical Nutrition Market, by Country, 2022 & 2028 (%)
  • Figure 103. Mexico: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 104. Brazil: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 105. Argentina: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 106. Chile: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 107. Peru: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 108. Colombia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 109. Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 110. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 111. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 112. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 113. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 114. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 115. Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
目次
Product Code: TIPRE00029916

The enteral and parenteral medical nutrition market size is expected to grow from US$ 17.34 billion in 2022 to US$ 25.47 billion by 2028; it is estimated to record a CAGR of 6.8% from 2023 to 2028.

The enteral and parenteral medical nutrition market growth is attributed to the rise in the prevalence of gastrointestinal diseases and increasing cases of malnutrition and premature births.

There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Nutritional requirements differ based on the type of illness. Functionality and specific formulations of the enteral and parenteral products do not interfere with the existing treatment provided to patients and help deliver a more precise and enhanced treatment as per the requirement. The macro and micronutrient formulations of enteral and parenteral nutrition and its applications vary based on various diseases, such as cancer and gastrointestinal diseases. Moreover, pharmaceutical companies provide enteral and parenteral nutrition with individualized (patient-specific) constituents. For example, Impact (offered by Nestle) is a clinically proven nutritional solution for managing patients undergoing major elective surgeries to reduce postoperative complications and hospital stay duration and improve clinical outcomes. Efforts of companies for offering such formulations for unique need will propel the growth of the enteral and parenteral medical nutrition market.

Additionally, various organizations are making efforts to spread awareness of the use of specific nutritional formulations. For instance, the American Society for Parenteral and Enteral Nutrition (called ASPEN) is a US-based medical professional organization that employs dietitians, pharmacists, physicians and assistants, nurses, nurse practitioners, scientists, students, and other health professionals from every field of nutrition to provide clinical nutrition to patients and educate them. Such factors will support the enteral and parenteral medical nutrition market growth in the future.

Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are more likely to show intolerance to artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. Thus, the fewer ingredients, the better the final product. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. According to Abbott, consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to propose plant-based meal options to improve patients' health. States including California, New York, and the District of Columbia have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral and parenteral medical nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults. Similarly, olive oil-based parenteral nutrition products are also gaining popularity.

Therefore, functional, and patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral and parenteral medical nutrition market.

Age Group -Based Insights

Based on age group, the enteral and parenteral medical nutrition market is categorized into above 60 years, 18-60 years, 3-18 years, and below 3 years. In 2022, the above 60 years segment accounted for the largest share in enteral and parenteral medical nutrition market. However, the 18-60 years segment is anticipated to register the highest CAGR during the forecast period. Weight loss and malnutrition are common in people aged above 60 years. With increasing age, the immunity of the older population decreases, and they become more prone to diseases that may deteriorate their health. Due to this, doctors prescribe external nutrition to maintain immunity and weight. According to several studies published in PubMed Central, the prevalence of chronic diseases and disabilities is significantly higher among geriatric people, generating the need for home-based treatments. Also, as per the Population Reference Bureau (2019), it is estimated that the senior population of the US is expected to grow from 52 million in 2018 to 95 million by 2060. The need for home therapy has increased due to the growing demand for home care owing to disability among old age groups. Thus, the increasing geriatric population base is expected to promote the growth of segment in the enteral and parenteral medical nutrition market.

The British Association for Parenteral and Enteral Nutrition, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the enteral and parenteral medical nutrition market report.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the enteral and parenteral medical nutrition market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global enteral and parenteral medical nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Enteral and Parenteral Medical Nutrition Market - By Indication
    • 1.3.2 Global Enteral and Parenteral Medical Nutrition Market - By Nutrition Type
    • 1.3.3 Global Enteral and Parenteral Medical Nutrition Market - By Form
    • 1.3.4 Global Enteral and Parenteral Medical Nutrition Market - By Product Type
    • 1.3.5 Global Enteral and Parenteral Medical Nutrition Market - By Route of Administration
    • 1.3.6 Global Enteral and Parenteral Medical Nutrition Market - By Age Group
    • 1.3.7 Global Enteral and Parenteral Medical Nutrition Market - By Distribution Channel
    • 1.3.8 Global Enteral and Parenteral Medical Nutrition Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Enteral and Parenteral Medical Nutrition Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East and Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion
  • 4.4 Energy Content Analysis
    • 4.4.1 Lower than 1.5 kcal/ml
    • 4.4.2 Equals to 1.5 kcal/ml
    • 4.4.3 Lower than 2kcal/ml:
    • 4.4.4 Equal to or Higher than 2kcal/ml:

5. Enteral and Parenteral Medical Nutrition Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Gastrointestinal Diseases
    • 5.1.2 Increasing Cases of Malnutrition and Premature Births
  • 5.2 Market Restraints
    • 5.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Enteral and Parenteral Feeding Systems, and Limitations Related to Catheter Placement
  • 5.3 Market Opportunities
    • 5.3.1 Growing Strategic Initiatives by Companies
  • 5.4 Future Trends
    • 5.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 5.5 Impact Analysis

6. Enteral and Parenteral Medical Nutrition Market - Global Analysis

  • 6.1 Global Enteral and Parenteral Medical Nutrition Market Revenue Forecast and Analysis
    • 6.1.1 Global Enteral and Parenteral Medical Nutrition Market, By Geography - Forecast and Analysis
  • 6.2 Company Analysis
    • 6.2.1 Market Positioning of Key Players
  • 6.3 Market Share Analysis of Enteral and Parenteral Medical Nutrition Market

7. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Indication

  • 7.1 Overview
  • 7.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Indication 2022 & 2028 (%)
    • 7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Indication, 2020-2028 (US$ Million)
  • 7.3 Elderly
    • 7.3.1 Overview
    • 7.3.2 Elderly: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Elderly by Form, 2020-2028 (US$ Million)
  • 7.4 Gastrointestinal Disorders
    • 7.4.1 Overview
    • 7.4.2 Gastrointestinal Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Gastrointestinal Disorders by Form, 2020-2028 (US$ Million)
    • 7.4.3 Inflammatory Bowel Disease
      • 7.4.3.1 Overview
      • 7.4.3.2 IBD: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.3.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBD by Form, 2020-2028 (US$ Million)
    • 7.4.4 Irritable Bowel Syndrome
      • 7.4.4.1 Overview
      • 7.4.4.2 IBS: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.4.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For IBS by Form, 2020-2028 (US$ Million)
    • 7.4.6 Others
      • 7.4.6.1 Overview
      • 7.4.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Others by Form, 2020-2028 (US$ Million)
  • 7.5 Diabetes
    • 7.5.1 Overview
    • 7.5.2 Diabetes: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1.1 Global: Enteral and Parenteral Medical Nutrition Market, For Diabetes by Form, 2020-2028 (US$ Million)
  • 7.6 Cancer
    • 7.6.1 Overview
    • 7.6.2 Cancer: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.6.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Cancer by Form, 2020-2028 (US$ Million)
  • 7.7 Respiratory Disorders
    • 7.7.1 Overview
    • 7.7.2 Respiratory Disorders: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.7.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Respiratory Disorders by Form, 2020-2028 (US$ Million)
  • 7.8 Alzheimer's Disease
    • 7.8.1 Overview
    • 7.8.2 Alzheimer's Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Alzheimer's Disease by Form, 2020-2028 (US$ Million)
  • 7.9 Dementia
    • 7.9.1 Overview
    • 7.9.2 Dementia: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Dementia by Form, 2020-2028 (US$ Million)
  • 7.10 Renal Disease
    • 7.10.1 Overview
    • 7.10.2 Renal Disease: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Renal Disease by Form, 2020-2028 (US$ Million)
  • 7.11 Liver Failure
    • 7.11.1 Overview
    • 7.11.2 Liver Failure: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Liver Failure by Form, 2020-2028 (US$ Million)
  • 7.12 Post COVID-19
    • 7.12.1 Overview
    • 7.12.2 Post COVID-19: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Post COVID-19 by Form, 2020-2028 (US$ Million)
  • 7.13 Other Indications
    • 7.13.1 Overview
    • 7.13.2 Other Indications: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
      • 7.13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, For Other Indications by Form, 2020-2028 (US$ Million)

8. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Nutrition Type

  • 8.1 Overview
  • 8.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Nutrition Type 2022 & 2028 (%)
    • 8.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Nutrition Type, 2020-2028 (US$ Million)
  • 8.3 Supplemental
    • 8.3.1 Overview
    • 8.3.2 Supplemental: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Sole-Source
    • 8.4.1 Overview
    • 8.4.2 Sole-Source: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Form

  • 9.1 Overview
  • 9.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Form 2022 & 2028 (%)
    • 9.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Form, 2020-2028 (US$ Million)
  • 9.3 Liquid
    • 9.3.1 Overview
    • 9.3.2 Liquid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Powder
    • 9.4.1 Overview
    • 9.4.2 Powder: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Semi-Solid
    • 9.5.1 Overview
    • 9.5.2 Semi-Solid: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

10. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Product Type

  • 10.1 Overview
  • 10.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Product Type 2022 & 2028 (%)
    • 10.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Product Type, 2020-2028 (US$ Million)
  • 10.3 General
    • 10.3.1 Overview
    • 10.3.2 General: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Disease-Specific
    • 10.4.1 Overview
    • 10.4.2 Disease-Specific: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

11. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Route of Administration

  • 11.1 Overview
  • 11.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Route of Administration 2022 & 2028 (%)
    • 11.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Route of Administration, 2020-2028 (US$ Million)
  • 11.3 Oral
    • 11.3.1 Overview
    • 11.3.2 Oral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.4 Tube Feed
    • 11.4.1 Overview
    • 11.4.2 Tube Feed: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 11.5 Parenteral
    • 11.5.1 Overview
    • 11.5.2 Parenteral: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

12. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Age Group

  • 12.1 Overview
  • 12.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Age Group 2022 & 2028 (%)
    • 12.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Age Group, 2020-2028 (US$ Million)
  • 12.3 Above 60 Years
    • 12.3.1 Overview
    • 12.3.2 Above 60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.4 18-60 Years
    • 12.4.1 Overview
    • 12.4.2 18-60 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.5 3-18 Years
    • 12.5.1 Overview
    • 12.5.2 3-18 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 12.6 Below 3 Years
    • 12.6.1 Overview
    • 12.6.2 Below 3 Years: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

13. Global Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - by Distribution Channel

  • 13.1 Overview
  • 13.2 Enteral and Parenteral Medical Nutrition Market Revenue Share, by Distribution Channel 2022 & 2028 (%)
    • 13.2.1 Global: Enteral and Parenteral Medical Nutrition Market, by Distribution Channel, 2020-2028 (US$ Million)
  • 13.3 Hospital Pharmacies
    • 13.3.1 Overview
    • 13.3.2 Hospital Pharmacies: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.4 Retail Stores
    • 13.4.1 Overview
    • 13.4.2 Retail Stores: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.5 E-Commerce
    • 13.5.1 Overview
    • 13.5.2 E-Commerce: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 13.6 Others
    • 13.6.1 Overview
    • 13.6.2 Others: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)

14. Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 14.1 North America: Enteral and Parenteral Medical Nutrition Market
    • 14.1.9.1 US: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.1.9.2 Canada: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
  • 14.2 Europe: Enteral and Parenteral Medical Nutrition Market
    • 14.2.1 Overview
    • 14.2.10.1 Germany: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.2 UK: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.3 France: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.4 Italy: Enteral and Parenteral Medical Nutrition Market - Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.5 Spain: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.6 Netherlands: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.7 Switzerland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.8 Poland: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.9 Sweden: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.10 Belgium: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.2.10.11 Rest of Europe: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.3 Asia Pacific: Enteral and Parenteral Medical Nutrition Market
    • 14.3.1 Overview
    • 14.3.9.1 China: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.1.1 Overview
    • 14.3.9.2 Japan: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.3 India: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.4 Australia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.5 South Korea: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.6 Indonesia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.7 Thailand: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.8 Vietnam: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.3.9.9 Rest of Asia Pacific: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.4 Middle East & Africa Enteral and Parenteral Medical Nutrition Market
    • 14.4.1 Overview
    • 14.4.9.1 Saudi Arabia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.2 South Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.3 UAE: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.4 Iran: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.5 Israel: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.6 Egypt: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.4.9.7 Rest of Middle East & Africa: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
  • 14.5 South & Central America Enteral and Parenteral Medical Nutrition Market
    • 14.5.1 Overview
    • 14.5.10.1 Mexico: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.2 Brazil: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.3 Argentina: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.4 Chile: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.5 Peru: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.6 Colombia: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)
    • 14.5.10.7 Rest of South & Central America: Enteral and Parenteral Medical Nutrition Market – Revenue and Forecast to 2028 (US$ Million)

    15. Impact Of COVID-19 Pandemic on Enteral and Parenteral Medical Nutrition Market

    • 15.1 North America: Impact Assessment of COVID-19 Pandemic
    • 15.2 Europe: Impact Assessment of COVID-19 Pandemic
    • 15.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
    • 15.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
    • 15.5 South & Central America: Impact Assessment of COVID-19 Pandemic

    16. Enteral and Parenteral Medical Nutrition Market – Industry Landscape

    • 16.1 Overview
    • 16.2 Growth Strategies in the Enteral and Parenteral Medical Nutrition Market
    • 16.3 Inorganic Growth Strategies
    • 16.3.1 Overview
    • 16.4 Organic Growth Strategies
    • 16.4.1 Overview

    17. Company Profiles

    • 17.1 Abbott Laboratories
      • 17.1.1 Key Facts
      • 17.1.2 Business Description
      • 17.1.3 Products and Services
      • 17.1.4 Financial Overview
      • 17.1.5 SWOT Analysis
      • 17.1.6 Key Developments
    • 17.2 Nestle SA
      • 17.2.1 Key Facts
      • 17.2.2 Business Description
      • 17.2.3 Products and Services
      • 17.2.4 Financial Overview
      • 17.2.5 SWOT Analysis
      • 17.2.6 Key Developments
    • 17.3 Nutricia International BV
      • 17.3.1 Key Facts
      • 17.3.2 Business Description
      • 17.3.3 Products and Services
      • 17.3.4 Financial Overview
      • 17.3.5 SWOT Analysis
      • 17.3.6 Key Developments
    • 17.4 Medtrition Inc
      • 17.4.1 Key Facts
      • 17.4.2 Business Description
      • 17.4.3 Products and Services
      • 17.4.4 Financial Overview
      • 17.4.5 SWOT Analysis
      • 17.4.6 Key Developments
    • 17.5 Fresenius Kabi AG
      • 17.5.1 Key Facts
      • 17.5.2 Business Description
      • 17.5.3 Products and Services
      • 17.5.4 Financial Overview
      • 17.5.5 SWOT Analysis
      • 17.5.6 Key Developments
    • 17.6 B. Braun SE
      • 17.6.1 Key Facts
      • 17.6.2 Business Description
      • 17.6.3 Products and Services
      • 17.6.4 Financial Overview
      • 17.6.5 SWOT Analysis
      • 17.6.6 Key Developments
    • 17.7 Smartfish AS
      • 17.7.1 Key Facts
      • 17.7.2 Business Description
      • 17.7.3 Products and Services
      • 17.7.4 Financial Overview
      • 17.7.5 SWOT Analysis
      • 17.7.6 Key Developments
    • 17.8 Nutrisens SAS
      • 17.8.1 Key Facts
      • 17.8.2 Business Description
      • 17.8.3 Products and Services
      • 17.8.4 Financial Overview
      • 17.8.5 SWOT Analysis
      • 17.8.6 Key Developments
    • 17.9 AYMES International Ltd
      • 17.9.1 Key Facts
      • 17.9.2 Business Description
      • 17.9.3 Products and Services
      • 17.9.4 Financial Overview
      • 17.9.5 SWOT Analysis
      • 17.9.6 Key Developments
    • 17.10 Medifood International SA
      • 17.10.1 Key Facts
      • 17.10.2 Business Description
      • 17.10.3 Products and Services
      • 17.10.4 Financial Overview
      • 17.10.5 SWOT Analysis
      • 17.10.6 Key Developments
    • 17.11 Easy Line Ltd
      • 17.11.1 Key Facts
      • 17.11.2 Business Description
      • 17.11.3 Products and Services
      • 17.11.4 Financial Overview
      • 17.11.5 SWOT Analysis
      • 17.11.6 Key Developments
    • 17.12 Charing Cross Scientific AS
      • 17.12.1 Key Facts
      • 17.12.2 Business Description
      • 17.12.3 Products and Services
      • 17.12.4 Financial Overview
      • 17.12.5 SWOT Analysis
      • 17.12.6 Key Developments
    • 17.13 Baxter International Inc
      • 17.13.1 Key Facts
      • 17.13.2 Business Description
      • 17.13.3 Products and Services
      • 17.13.4 Financial Overview
      • 17.13.5 SWOT Analysis
      • 17.13.6 Key Developments
    • 17.14 Medica Nutrition Inc
      • 17.14.1 Key Facts
      • 17.14.2 Business Description
      • 17.14.3 Products and Services
      • 17.14.4 Financial Overview
      • 17.14.5 SWOT Analysis
      • 17.14.6 Key Developments

    18. Appendix

    • 18.1 About The Insight Partners
    • 18.2 Glossary of Terms